DoH Equality policies screened 1 January to 31 March 2016
Date published:
In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact assessment (EQIA).
Documents
- NICE Technology Appraisal - TA369 - Ciclosporin for treating dry eye disease which has not improved after treatment with artificial tears
- NICE Technology Appraisal TA370 - Bortezomib for previously untreated mantle cell lymphoma
- NICE Technology Appraisal TA371 - Trastuzumab emtansine for treating HER2-positive, unresectable locally advanced or metastatic breast cancer after treatment with trastuzumab and a taxane
- NICE Technology Appraisal TA372 - Apremilast for treating active psoriatic arthritis
- NICE Technology Appraisal - TA373 - Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (including review of TA35)
- NICE Clinical Guideline NG23 - Menopause: diagnosis and management
- NICE Technology Appraisal - TA374 - Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed following prior chemotherapy (Review of TA162 and TA175)
- NICE (Clinical) Guidance NG24 - Blood transfusion
- NICE (Clinical) Guidance NG25 - Preterm labour and birth
- Alignment of Part IX of the NI Drug Tariff with Part XVII of the English Drug Tariff– Lists of preparations that can be prescribed by dentists and nurses
- NICE Clinical Guideline CG150 - Headaches in over 12s: diagnosis and management – Addendum
- NICE Clinical Guideline NICE CG144 - Venous thromboembolic diseases: diagnosis, management and thrombophilia testing – Addendum
- The draft Human Trafficking and Exploitation (Criminal Justice and Support for Victims) (Independent Guardian) Regulations (Northern Ireland) (“the Independent Guardian Regulations”)
- NICE Clinical Guideline CG79 – Rheumatoid arthritis in adults: management – Addendum
- NICE Guideline NG28 - Type 2 diabetes in adults: management. This guideline updates and replaces NICE guidelines CG66, CG87 and NICE technology appraisals TA203 and TA248
- NICE Guideline NG31 – Care of dying adults in the last days of life
- NICE Technology Appraisal TA376 - Radium-223 dichloride for treating adults with hormone-relapsed prostate cancer, symptomatic bone metastases and no known visceral metastases
- NICE Technology Appraisal TA 375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
- NICE Technology Appraisal TA378 - Ramucirumab for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma after chemotherapy
- NICE Technology Appraisal TA379 - Nintedanib for treating idiopathic pulmonary fibrosis
- NICE Technology Appraisal - TA380 - Panobinostat for treating multiple myeloma in people who have received at least one prior therapy
- NICE Technology Appraisal TA381 - Olaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube and peritoneal cancer after response to second-line or subsequent platinum-based chemotherapy
- NICE Technology Appraisal TA377 - Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
- The Firefighters’ Compensation Scheme (Amendment) (No 2) and The New Firefighters Pension Scheme (Amendment) (No 4) Order (Northern Ireland) 2015
- NICE Technology Appraisal TA 383 - TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis (including a review of TA143 and TA233)
- The Firefighters’ Pension Scheme (Consequential Provisions) (Amendment) Regulations (Northern Ireland) 2016
- NICE Technology Appraisal TA 384 - Nivolumab for treating advanced (unresectable or metastatic) melanoma
- NICE Technology Appraisal TA 385 - Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia (review of TA132)
- Closure of the Independent Living Fund (ILF) by the Department for Work and Pensions (DWP) with transfer of responsibility and funding to devolved administrations (including Northern Ireland)
- Stopping Domestic and Sexual Violence and Abuse in Northern Ireland
- Leaving Prostitution: a strategy for help and support
- The Firefighters’ Pension Scheme (Transitional and Consequential Provisions) Regulations (Northern Ireland) 2015